Trial Profile
Comparison of the Effects of Combination Atorvastatin (40 mg) + Ezetimibe (10 mg) Versus Atorvastatin (40 mg) Alone on Secretory Phospholipase A2 Activity in Patients With Stable Coronary Artery Disease or Coronary Artery Disease Equivalent
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2011
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Atorvastatin/ezetimibe (Primary)
- Indications Atherosclerosis; Coronary artery disease
- Focus Pharmacodynamics
- 19 Apr 2011 New trial record